C21 · Pharmaceuticals · Global
Patients treated with drug
Global: 10,000 in as of 10 Sep 2026.
- 10,000 Latest · Global · as of 10 Sep 2026
- Irregular Release cadence
- 1 Record · 1 region · 2026
Verified 15 Sep 2026 · 1 publisher
The figure
One published observation so far. A chart follows as soon as a second period is published.
Patients treated with drug
Global, as of 10 Sep 2026
Every record
1 record · 1 region · 2026. Each period links to its record: the value, its source evidence and original document.
| Period | Value | Source | Type |
|---|---|---|---|
| Global 1 record | |||
| as of 10 Sep 2026 | 10,000 | Roche · 10 Sep 2026 | |
Download this data
Every file carries its provenance: the CSV has a source column per row, and the chart images print the publisher, the licence and this page's address under the drawing. Source: Roche. Licence: CC BY 4.0.
Use and publication rights
- View, cite and link: free
Quote any number, cite this page or a single record, and link to it anywhere.
- Copy, chart and republish: free with attribution
The data is published under CC BY 4.0, commercial use included. Credit StatOrigin and the original publisher (Roche); the chart files already carry that line.
- The source documents: the publisher's terms
Figures are facts read from the publishers' own documents. The documents themselves, their text and design, stay under each publisher's terms; follow the source links for those.
How this measure is built
- Definition
- Cumulative number of patients in whom a medicine has an established safety profile through clinical trials and post-approval use.
- Measure
- One slice of Patients treated ( basis: cumulative, form: count, segment: company reported ) . Total number of patients who have received treatment with a therapeutic product. Region and period are columns on every record, not slices.
- Limitations
- Values are shown as published; StatOrigin does not revise, fill gaps or convert currencies.
- Verification
- Each value, unit, period and place was checked against its source evidence before publication. See the methodology and the corrections process.
Sources · 1 document
| Document | Publisher | Published | Data points |
|---|---|---|---|
| U.S. FDA grants Priority Review for Roche’s Enspryng for MOGAD, an autoimmune disease with no approved treatments | Roche | 10 Sep 2026 | 1 |
Frequently asked questions
What is the latest patients treated with drug?
Global: 10,000 in as of 10 Sep 2026.
Where does this data come from?
From 1 document published by Roche. Every figure on this page links to its record, which preserves the original source evidence.
How often is it updated?
Irregularly: the publishers behind this measure do not release it on a fixed schedule. A new figure appears here once it is published and verified.
Can I use this data?
Yes. StatOrigin publishes it under CC BY 4.0: you may copy, chart and republish it, including commercially, with attribution to StatOrigin and to the original publisher.
Cite this page
Cite the page as a data set, or open any record to cite one figure: each record carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Patients treated with drug [Data set]. Retrieved October 28, 2026, from https://statorigin.org/indicators/patients-treated-with-drug
"Patients treated with drug." StatOrigin, 2026, https://statorigin.org/indicators/patients-treated-with-drug. Accessed 28 Oct. 2026.
StatOrigin. "Patients treated with drug." Data set, 2026. Accessed October 28, 2026. https://statorigin.org/indicators/patients-treated-with-drug.
@misc{statorigin_patients_treated_with_drug_2026, title = {Patients treated with drug}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/indicators/patients-treated-with-drug}, note = {Data set. Accessed 2026-10-28} }